A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

Exclusion Criteria

• •Participants for whom participating would significantly delay the scheduled standard of care therapy.
• •Subjects must not have prostate biopsies performed within 12 weeks before imaging; or within 8 weeks before imaging providing that the absence of hemorrhage is confirmed by MR imaging.
• •SGOT and SGPT ≥ 2 x of the upper limits of normal; total bilirubin, of ≥ 1.5 x the upper limits of normal or ≥ 3.0 mg/dl in patients with Gilbert's syndrome.
• •Administered a radioisotope within 5 physical half lives prior to study enrollment.
• •Patients with severe claustrophobia unresponsive to oral anxiolytics
• •Subjects weighing ≥350 lbs or are unable to fit within the imaging gantry
• •Subjects who have received androgen deprivation therapy.
• •Subjects with any medical condition or other circumstances that, in the opinion of the Investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study.